Fork Protection and Therapy Resistance in Hereditary Breast Cancer.

about

Fork Protection and Therapy Resistance in Hereditary Breast Cancer.

Item

http://www.wikidata.org/entity/Q53707073

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Fork Protection and Therapy Resistance in Hereditary Breast Cancer.

@en

Fork Protection and Therapy Resistance in Hereditary Breast Cancer.

@nl

type

Item

label

Fork Protection and Therapy Resistance in Hereditary Breast Cancer.

@en

Fork Protection and Therapy Resistance in Hereditary Breast Cancer.

@nl

prefLabel

Fork Protection and Therapy Resistance in Hereditary Breast Cancer.

@en

Fork Protection and Therapy Resistance in Hereditary Breast Cancer.

@nl

P1476

Fork Protection and Therapy Resistance in Hereditary Breast Cancer.

@en

P2093

Jennifer A Calvo

http://www.w3.org/2001/XMLSchema#string

Sharon B Cantor

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of Rev1 by the Fanconi anemia core complex

Polyubiquitinated PCNA recruits the ZRANB3 translocase to maintain genomic integrity after replication stress

Transcriptional repressor ZBTB1 promotes chromatin remodeling and translesion DNA synthesis

Stabilization of stalled DNA replication forks by the BRCA2 breast cancer susceptibility protein

Suppression of Rev3, the catalytic subunit of Pol{zeta}, sensitizes drug-resistant lung tumors to chemotherapy

A Dominant Mutation in Human RAD51 Reveals Its Function in DNA Interstrand Crosslink Repair Independent of Homologous Recombination

A novel Fanconi anaemia subtype associated with a dominant-negative mutation in RAD51

Resistance to therapy caused by intragenic deletion in BRCA2

Ubiquitinated Fancd2 recruits Fan1 to stalled replication forks to prevent genome instability

RAD52 inactivation is synthetically lethal with deficiencies in BRCA1 and PALB2 in addition to BRCA2 through RAD51-mediated homologous recombination

P304

339-348

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1101/SQB.2017.82.034413

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29472318

http://www.w3.org/2001/XMLSchema#string

P932

6041132

http://www.w3.org/2001/XMLSchema#string